Germany Prioritizes Medical Biotechnology with New Initiatives

BERLIN AND BOSTON, Sept. 17, 2012 /CNW/ - The new round of funding by
Germany's Ministry of Education and Research will provide EUR 40
million for biotechnology research. At the same time, the Health-Made in Germany initiative has been set up to turn Germany into a business hub for the
international healthcare industry. With these new initiatives, Germany
is consolidating its position as Europe's top medical biotechnology
location.

"We are hosting a breakfast seminar on September 18 in Boston to bring
together important players from the German and American biotechnology
sectors. One of Germany's top clusters, BioM Munich and Massachusetts
association MassBio will have a chance to highlight bilateral ties.
This meeting will be a great start to this year's BioPharm America
2012, happening from September 19-21 in Boston," stated Sandra Buetow,
pharmaceutical industry expert for Germany Trade & Invest in Berlin.

Germany features over 500 dedicated biotechnology companies. Nearly half
of these companies develop new drugs or diagnostic methods in the areas
of human and animal medicine, making this one of the most important
applications of biotechnology. The United States is the top investor in
Germany, according to Germany Trade & Invest statistics. At the same time, the USA is an essential market for German
exports.

Health-Made in Germany is an initiative to create win-win situations for global partners and
German healthcare companies. Supported by the Federal Ministry of
Economics and Technology and carried out by Germany Trade & Invest, the initiative allows companies, federal clusters, and professional
associations to benefit from business opportunities in the healthcare
field.

Germany Trade & Invest is the foreign trade and inward investment promotion agency of the
Federal Republic of Germany. The organization advises foreign companies
looking to expand their business activities in the German market. It
provides information on foreign trade to German companies that seek to
enter foreign markets.